| FullText URL | fulltext.pdf |
|---|---|
| Author | Murakami, Hiroyuki| Matsuoka, Ken-Ichi| Asano, Takeru| Moriyama, Takashi| Matsumura, Akifumi| Fujiwara, Hideaki| Asada, Noboru| Ennishi, Daisuke| Nishimori, Hisakazu| Fujii, Keiko| Fujii, Nobuharu| Toji, Tomohiro| Yoshino, Tadashi| Maeda, Yoshinobu| |
| Keywords | Refractory acute myeloid leukemia Transplant B-cell lymphoma-2 Azacitidine Venetoclax |
| Published Date | 2022-11-08 |
| Publication Title | Case Reports In Oncology |
| Volume | volume15 |
| Issue | issue3 |
| Publisher | Karger |
| Start Page | 974 |
| End Page | 979 |
| ISSN | 1662-6575 |
| NCID | AA12780955 |
| Content Type | Journal Article |
| language | English |
| OAI-PMH Set | 岡山大学 |
| Copyright Holders | © 2022 The Author(s). |
| File Version | publisher |
| PubMed ID | 36636684 |
| DOI | 10.1159/000526697 |
| Web of Science KeyUT | 000905485600025 |
| Related Url | isVersionOf https://doi.org/10.1159/000526697 |
| FullText URL | fulltext.pdf |
|---|---|
| Author | Meguri, Yusuke| Asano, Takeru| Yoshioka, Takanori| Iwamoto, Miki| Ikegawa, Shuntaro| Sugiura, Hiroyuki| Kishi, Yuriko| Nakamura, Makoto| Sando, Yasuhisa| Kondo, Takumi| Sumii, Yuichi| Maeda, Yoshinobu| Matsuoka, Ken-Ichi| |
| Keywords | regulatory T cell low-dose interleukin-2 therapy graft-versus-host disease graft-versus-leukemia effect transplantation tolerance |
| Published Date | 2022-08-02 |
| Publication Title | Frontiers In Immunology |
| Volume | volume13 |
| Publisher | Frontiers Media |
| Start Page | 891925 |
| ISSN | 1664-3224 |
| Content Type | Journal Article |
| language | English |
| OAI-PMH Set | 岡山大学 |
| Copyright Holders | © 2022 Meguri, Asano, Yoshioka, Iwamoto, Ikegawa, Sugiura, Kishi, Nakamura, Sando, Kondo, Sumii, Maeda and Matsuoka. |
| File Version | publisher |
| PubMed ID | 35983059 |
| DOI | 10.3389/fimmu.2022.891925 |
| Web of Science KeyUT | 000844642000001 |
| Related Url | isVersionOf https://doi.org/10.3389/fimmu.2022.891925 |
| JaLCDOI | 10.18926/AMO/54608 |
|---|---|
| FullText URL | 70_5_429.pdf |
| Author | Asano, Takeru| Matsuoka, Ken-ichi| Iyama, Satoshi| Ohashi, Kazuteru| Inamoto, Yoshihiro| Ohwada, Chikako| Murata, Makoto| Satake, Atsushi| Yoshida, Chikamasa| Nakase, Koichi| Mori, Yasuo| Tanimoto, Mitsune| |
| Abstract | Chronic graft versus host disease (cGVHD) remains a major problem for long survivors after allogeneic hematopoietic stem cell transplantation (HSCT). Currently, corticosteroid therapy is effective for cGVHD as the first line therapy. However, prolonged therapy with corticosteroids causes various severe adverse events. To develop the new therapeutic strategy of cGVHD, we have launched a multicenter phase I/IIa clinical trial of low dose subcutaneous interleukin-2 (IL-2) for treatment of steroid refractory cGVHD, which is constituted of 2 sequential phases (induction phase and maitanance phase). This study will provide the new therapeutic option for patients with refractory cGVHD after allogeneic HSCT. |
| Keywords | chronic GVHD allogeneic HSCT steroid refractory IL-2 |
| Amo Type | Clinical Study Protocols |
| Publication Title | Acta Medica Okayama |
| Published Date | 2016-10 |
| Volume | volume70 |
| Issue | issue5 |
| Publisher | Okayama University Medical School |
| Start Page | 429 |
| End Page | 433 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2016 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 27777442 |
| Web of Science KeyUT | 000388098700019 |
